A young mom battling stage 4 cancer says she was supposed to start a clinical trial at the National Institutes of Health in just a few weeks — but she was left in limbo after her doctors told her she could no longer take part in the trial due to funding issues.
But late Friday night, she breathed a sigh of relief: Her appeal to get the trial drugs sent to Canada has now been approved.
The Trump administration recently tried to change NIH’s funding policy, to cut hundreds of millions of dollars in spending. It would have affected overhead costs, such as building maintenance and equipment. In response, a group of 22 states plus universities, hospitals, and research institutions are now suing. Just days ago, a federal judge in Boston sided with the states, and temporarily blocked the funding cuts.
But the cancer patient we spoke with said Friday …